- Home
- WFC vs TMO Comparison
WFC vs TMO Comparison
Compare WFC & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- TMO
- Stock Information
- Founded
- WFC 1852
- TMO 1956
- Country
- WFC United States
- TMO United States
- Employees
- WFC N/A
- TMO N/A
- Industry
- WFC Major Banks
- TMO Industrial Machinery/Components
- Sector
- WFC Finance
- TMO Industrials
- Exchange
- WFC Nasdaq
- TMO Nasdaq
- Market Cap
- WFC 235.8B
- TMO 211.0B
- IPO Year
- WFC N/A
- TMO N/A
- Fundamental
- Price
- WFC $70.36
- TMO $523.89
- Analyst Decision
- WFC Buy
- TMO Strong Buy
- Analyst Count
- WFC 22
- TMO 18
- Target Price
- WFC $67.82
- TMO $650.72
- AVG Volume (30 Days)
- WFC 18.5M
- TMO 2.3M
- Earning Date
- WFC 01-15-2025
- TMO 01-29-2025
- Dividend Yield
- WFC 2.27%
- TMO 0.30%
- EPS Growth
- WFC 1.87
- TMO 4.56
- EPS
- WFC 4.79
- TMO 15.95
- Revenue
- WFC $77,875,000,000.00
- TMO $42,370,000,000.00
- Revenue This Year
- WFC N/A
- TMO $0.85
- Revenue Next Year
- WFC $0.50
- TMO $5.15
- P/E Ratio
- WFC $14.69
- TMO $32.85
- Revenue Growth
- WFC 1.03
- TMO N/A
- 52 Week Low
- WFC $46.12
- TMO $493.30
- 52 Week High
- WFC $78.13
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- WFC 46.28
- TMO 44.94
- Support Level
- WFC $68.61
- TMO $508.86
- Resistance Level
- WFC $72.29
- TMO $535.94
- Average True Range (ATR)
- WFC 1.73
- TMO 10.26
- MACD
- WFC -0.79
- TMO 0.76
- Stochastic Oscillator
- WFC 24.10
- TMO 44.81
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).